Correlation between betatrophin/angiogenin-likeprotein3/lipoprotein lipase pathway and severity of coronary artery disease in Kazakh patients with coronary heart disease

doi:10.12998/wjcc.v10.i7.2095

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 7

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5634)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

217

WORD

116

HTML

2532

Figures (1-3)

381

Tables (1-5)

339

Sum=3585

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

389

Download

560

Sum=949

Publishing Process of This Article

Item

Count

Browse

341

Download

759

Sum=1100

Mar 6, 2022 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Clin Cases. Mar 6, 2022; 10(7): 2095-2105
Published online Mar 6, 2022. doi: 10.12998/wjcc.v10.i7.2095

Table 1 Comparison of general baseline data between Kazakh and Han patients with coronary heart disease

Variables	Kazakh			Han
Variables	CHD (n = 79)	Non-CHD (n = 72)	P value	CHD (n = 61)	Non-CHD (n = 65)	P value
Age (yr)	52.27 ± 12.10	53.77 ± 12.24	0.16	53.78 ± 13.56	52.63 ± 11.73	0.14
SBP (mmHg)	135.13 ± 15.46	129.24 ± 13.42	0.27	129.44 ± 15.69	125.58 ± 16.81	0.24
DBP (mmHg)	84.85 ± 13.21	81.34 ± 12.52	0.18	81.41 ± 16.39	79.26 ± 12.14	0.15
BMI	27.43 ± 2.97 ¹^,³	24.76 ± 3.22	0.007	26.74 ± 2.43²	24.22 ± 3.37	0.03
GLU (mmol/L)	5.53 ± 0.62	54.06 ± 14.16	0.26	5.16 ± 0.37	4.73 ± 0.52	0.24
Fructosamine (μmol/L)	241.82 ± 23.42	235.89 ± 18.54	0.33	246.02 ± 21.42	239.71 ± 18.25	0.13
HOMA-IR	0.95 ± 0.11	0.93 ± 0.09	0.13	0.89 ± 0.06	0.87 ± 0.07	0.09
HOMA-β	0.81 ± 0.06	0.80 ± 0.09	0.15	0.78 ± 0.14	0.79 ± 0.07	0.11
TC (mmol/L)	5.37 ± 0.73¹^,³	4.28 ± 0.34	0.005	5.01 ± 1.09²	4.12 ± 0.76	0.004
TG (mmol/L)	1.36 ± 0.60¹^,³	1.14 ± 0.56	0.007	1.15 ± 0.65²	1.08 ± 0.37	0.006
LDL-C (mmol/L)	3.15 ± 0.62¹^,³	2.56 ± 0.44	0.004	2.98 ± 1.02²	2.87 ± 0.56	0.02
HDL-C (mmol/L)	1.85 ± 0.39	1.93 ± 0.2 3	0.21	1.87 ± 0.38	2.01 ± 0.36	0.26

¹Comparison between Kazakh CHD patients and control group patients (P < 0.01).

²Comparison between Han CHD patients and control group patients (P < 0.05).

³Comparison between Kazakh and Han patients (P <0.01).

CHD: Coronary heart disease; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; BMI: Body mass index; GLU: Glucose; HOMA-IR: Homeostasis model assessment-insulin resistance; HOMA-β: Homeostasis model assessment-β cells; TC: Total cholesterol; TG: Triglycerides; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol.

Table 2 Comparison of serum betatrophin, angiopoietin-like protein 3 and lipoprotein lipase levels in coronary heart disease group and control group

Variables	Kazakh			Han
Variables	CHD (n = 79)	Non-CHD (n = 72)	P value	CHD (n = 61)	Non-CHD (n = 65)	P value
Betatrophin (pg/mL)	435.32 ± 60.36¹^,²	243.21 ± 62.73¹	< 0.001	408.26 ± 57.45²	219.73 ± 59.37	0.031
ANGPTL3 (ng/mL)	3.42 ± 1.63¹^,²	2.69 ± 1.33¹	0.022	3.27 ± 1.45²	2.52 ± 1.53	0.038
LPL (ng/mL)	56.37 ± 13.27¹^,²	42.37 ± 13.16¹	0.043	54.52 ± 14.52²	41.42 ± 12.26	0.021

¹Compared with control group (P < 0.05).

²P: Compared with Han CHD group (P < 0.05).

CHD: Coronary heart disease; SBP: Systolic blood pressure; ANGPTL3: Angiopoietin-like protein 3; LPL: Lipoprotein lipase.

Table 3 The levels of betatrophin, angiopoietin-like protein 3, and lipoprotein lipase were compared between the two coronary heart disease groups after stratification according to Gensini integral

	Groups	n	Betatrophi (pg/mL)	ANGPTL3 (ng/mL)	LPL (ng/mL)
Kazakh	Gensini ≤ 24	32	356.86 ± 58.61	2.34 ± 0.57	50.22 ± 12.27
	25 ≤ Gensini < 53	22	380.03 ± 61.56	3.56 ± 1.03	57.59 ± 10.41
	Gensini ≥ 53	18	452.74 ± 62.24¹^,²	5.94 ± 1.46¹^,²	59.35 ± 13.19¹^,²
Han	Gensini ≤ 24	35	326.07 ± 50.56	2.00 ± 1.32	50.16 ± 13.48³
	25 ≤ Gensini < 53	21	369.64 ± 53.44	3.33 ± 0.83	54.39 ± 12.33³
	Gensini ≥ 53	9	422.39 ± 59.14¹	5.19 ± 1.21¹	57.60 ± 12.35¹

¹Comparison between mild and moderate within the group (P < 0.05).

²Compared with Han CHD group (P < 0.05).

³Compared with Han CHD group (P > 0.05).

Angiopoietin-like protein 3; LPL: Lipoprotein lipase.

Table 4 Correlation between Gensini score and risk factors of atherosclerosis in two groups of patients with coronary heart disease

Group		TC (mmol/L)	TG (mmol/L)	LDL-C (mmol/L)	Betatrophin (pg/mL)	LPL (ng/mL)	BMI (ng/mL)
Kazakh	r	0.204	0.453	0.352	0.471	0.382	0.097
Kazakh	P value	0.043	0.009	0.048	0.001	0.001	0.261
Han	r	0.195	0.296	0.357	0.446	0.328	0.438
Han	P value	0.026	0.003	0.20	0.001	0.004	0.044

TC: Total cholesterol; TG: Triglycerides; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol; BMI: Body mass index; LPL: Lipoprotein lipase.

Table 5 Ordinal logistic regression analysis of two coronary heart disease groups

	Variables	B value	P value	Exp (B)
Kazakh	TG	3.292	0.03	3.632
Kazakh	Betatrophin	1.258	0.043	1.802
Han	BMI	5.635	0.01	2.457
Han	Betatrophin	1.170	0.036	1.615

TG: Triglycerides; BMI: Body mass index.

Citation: Qin L, Rehemuding R, Ainiwaer A, Ma X. Correlation between betatrophin/angiogenin-likeprotein3/lipoprotein lipase pathway and severity of coronary artery disease in Kazakh patients with coronary heart disease. World J Clin Cases 2022; 10(7): 2095-2105
URL: https://www.wjgnet.com/2307-8960/full/v10/i7/2095.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i7.2095